Company intelligence / Profile preview

Imricor Medical Systems

Burnsville, Minnesota, United Statesimricor.com ↗

Ownership: Private
Employees: ~110
Development stage: Commercial

Overview

Imricor has achieved CE mark approval for its Vision-MR Ablation Catheter to treat type 1 atrial flutter in the EU. The company has commenced first-in-human clinical trials for MRI-guided ventricular ablation using its NorthStar Mapping System and continues to expand indications and regulatory approvals globally. Early clinical results include successful elimination of complex arrhythmias with real-time MRI guidance at leading centers such as Amsterdam UMC

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Koninklijke Philips N.V.Siemens Healthcare GmbH

Beyond the preview

Go deeper on Imricor Medical Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Imricor Medical Systems.

Explore the full profile